Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 15.77
+0.62 (4.09%)
Feb 11, 2026, 3:59 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 312.5 million as of February 11, 2026. Its market cap has increased by 119.13% in one year.
Market Cap
312.50M
Enterprise Value
264.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
15.77
Market Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 312.50M, an increase of 431.17%. That is a compound annual growth rate of 45.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 312.50M | 155.24% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | 58.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.02B |
| Eupraxia Pharmaceuticals | 580.43M |
| NervGen Pharma | 426.12M |
| Helix BioPharma | 139.77M |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 68.40M |
| Sharp Therapeutics | 66.17M |
| NurExone Biologic | 61.66M |